Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06048133
Title Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors Nataliya Uboha
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.